Phase III data show benefits of azilsartan medoxomil potassium/chlorthalidone in hypertension June 2, 2011
RLY-5016 dose titration avoids hypokalemia in patients with heart failure and kidney disease June 1, 2011
Rivaroxaban is a viable option for secondary stroke prevention in patients with atrial fibrillation May 31, 2011
Interim phase II/III analysis points to benefits of Urocidin in non-muscle-invasive bladder cancer May 31, 2011
RSS